One of the most powerful aspects of the triple-network framework is that it gives a common language for therapies that look superficially different but converge on the same circuits. Pharmacological and non-pharmacological interventions are not in opposition; they are different routes to reshaping the same networks.
Cognitive-behavioral therapy (CBT) works partly by reducing DMN rumination. The patient learns to identify automatic negative thoughts (which arise from DMN activity), evaluate them against evidence, and substitute more accurate appraisals. Over weeks, this training appears to reduce DMN dominance and increase CEN control over automatic limbic responses. The therapy is not metaphorically changing thinking; it is changing network engagement patterns in measurable ways.
Mindfulness-based therapies — MBCT, MBSR, ACT — work partly by training the salience network to disengage from automatic DMN content. The practice of noticing when the mind has wandered to rumination, then gently returning to the breath, is essentially a repeated exercise in salience-network-mediated switching. Long-term meditators show altered salience network and DMN connectivity, with improved capacity to disengage from automatic self-referential content.
Stimulant medications work partly by strengthening CEN activation. Methylphenidate and amphetamines raise prefrontal dopamine, supporting working memory and task-focused attention. In ADHD this lets the patient engage the CEN on demand. In healthy adults the effect is less clear and may even degrade performance by pushing prefrontal dopamine past the optimal range.
SSRIs and SNRIs work, over weeks, to modulate the DMN. Effective antidepressant treatment is accompanied by measurable normalization of DMN activity, restoration of normal switching between networks, and reduced rumination. The slow timeline reflects the slow plasticity changes that underlie the network shift.
Psychedelics — psilocybin, LSD, DMT — work, in a single dose, to transiently dissolve the DMN's rigid self-referential pattern. The acute effect of disorganized self-narrative is the felt experience that has been described as ego dissolution. The therapeutic implication is that the brain, briefly freed from its habitual DMN pattern, can form new patterns of self-narrative that the rigid system could not otherwise reach. Clinical trials show robust antidepressant effects in single doses combined with psychotherapy.
Ketamine appears to work on both glutamatergic plasticity and network reset. The DMN is rapidly disrupted; salience and CEN engagement patterns shift; mood improves within hours. The plasticity changes that follow over days appear to consolidate the network shift.
Electroconvulsive therapy works partly through massive plasticity induction in mood-regulating networks. The exact network changes are not fully characterized, but ECT remains one of the most effective treatments for severe depression, and the working hypothesis is that it forces broad neural reset across the same systems.
Deep brain stimulation of the subgenual cingulate is being studied for treatment-resistant depression as a direct intervention on a key DMN node. Results have been mixed but the framework — directly stimulating a network hub that is over-active in depression — fits the triple-network model precisely.
Hold this synthesis. Therapies that look different — pills, talk therapy, meditation, electroconvulsive treatment, psychedelics — are all reshaping the same three networks by different molecular and behavioral routes. The framework integrates them. The clinical art is in choosing the right route for the right patient at the right time.